SAT0152 A Randomised, Double-Blind, Phase III Study Comparing SB2, An Infliximab Biosimilar, To the Infliximab Reference Product (Remicade®) in Patients with Moderate to Severe Rheumatoid Arthritis Despite Methotrexate Therapy
2015 ◽
Vol 74
(Suppl 2)
◽
pp. 706.3-707
◽
Keyword(s):
2016 ◽
Vol 75
(Suppl 2)
◽
pp. 231.1-231
Keyword(s):
2015 ◽
Vol 76
(1)
◽
pp. 58-64
◽
2016 ◽
Vol 75
(Suppl 2)
◽
pp. 234.2-234
2015 ◽
Vol 74
(Suppl 2)
◽
pp. 467.2-468
◽
Keyword(s):
2018 ◽
Vol 29
(6)
◽
pp. 919-927
◽
2019 ◽
Keyword(s):
Keyword(s):
Keyword(s):
2020 ◽
Vol 9
(8)
◽
pp. 1003-1014
◽
2017 ◽
Vol 77
(2)
◽
pp. 234-240
◽